Cargando…
Management of VEGFR-Targeted TKI for Thyroid Cancer
SIMPLE SUMMARY: Anti-VEGFR therapy has become a mainstay of treatment for thyroid cancer across histological subtypes. However, the inhibition of this pathway is associated with particular adverse effects, some of which are life-threatening and may lead to the withdrawal of definitive treatment. To...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8583039/ https://www.ncbi.nlm.nih.gov/pubmed/34771698 http://dx.doi.org/10.3390/cancers13215536 |